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Abstract: A stereoselective aminoiodination of activated alkynes with PhI(OAc)2 and amines via multiple-
site functionalization to afford (Z)diethyl 2-(diphenylamino)-3-iodomaleate derivatives with superior yields 
has been described. The key feature of this reaction is the incorporation of iodide and aryl group 
concurrently in the same molecule in a stereoselective manner by employing PhI(OAc)2 as electrophilic 
reagent as well as iodide and aryl group source. The high stereoselectivity of the reaction can be explained 
based on the structure of the possible intermediates, the conformations of which controlled by the hydrogen 
bonding, steric hindrance and electrostatic attractions. This reaction proceeds under mild conditions, 
providing various dialkyl 2-(diphenylamino)-3-iodomaleates by a single operation starting from activated 
alkynes. The robustness of our strategy is revealed by making of bis (dialkyl 2-(diphenylamino)-3-
iodomaleate) derivatives involving formation of four new C-N bonds and two C-I bonds with a single step. 
The synthesized inactive 3° enamines (dialkyl 2-(diphenylamino)-3-iodomaleates) could be further 
transformed into highly substituted indoles via Pd catalyzed C-H and C-I activation under non-acidic 
conditions.    
 
 Introduction 
Alkyne difunctionalizations have attracted intensive attention in recent years particularly in developing 
regio and stereoselective reactions to access multifunctional alkene products with broad synthetic and 
biological applications.1 For example the azidativehalo,2 sulfonative,3 aminohalogenative,4 silylzincative 5 
iodoacyloxylations6 and perfluoroalkylative7 difunctionalizations of alkynes have been successfully 
realized for the synthesis of various difunctionalization products. In this context, methods to produce 
halogenated enamines via aminohalogenation of alkynes are very attractive owing to the utility of these 
compounds in medicinal chemistry and organic synthesis.8 Accordingly, considerable efforts have been 
made to their syntheses resulting in various synthetic strategies. For example cyclic enaminones,9 2-
alkynyloxycarbonyl azides/amines/O-propargyl carbamates10 have been typically employed as precursors 
for halogenated enamines and catalyzed by metal or non-metals with various halogen sources.  
Scheme 1. Aminohalogenation of Alkynes and Our Strategy  
 
Furthermore, dehydrogenative aminohalogenation of alkenes via Pd catalysis was developed by 
Jiang and co-workers11 for the synthesis of brominated enamines. Later Li et al.12 developed Nickel or 
Diacetoxyiodobenzene promoted halogenation of enamines and enamides. However, examples of alkyne 
aminohalogenation towards halogenated enamines are scarce (Scheme 1a &b).13 For instance, Headley & 
Li and co-workers demonstrated the aminochlorination of arylalkynes with N,N 
dichlorobenzenesulfonamide (Scheme 1a).13a In 2014, Liang and Zhang et al. described the 
aminohalogenation of alkynes with N-haloimides activated by DBU (Scheme 1b).13b Despite this progress, 
developing the multiple-site functionalization of C-C multiple bonds with reagents as both halogen source 
as well as promoter in a stereoselective manner remains an intriguing challenge. As part of our ongoing 
study on multiple functionalization reactions of alkynes and amines using azides as nitrogen source and 
organoiodine compounds as promoter,14 we fancied to synthesize iodinated enamines directly from alkynes 
and amines by using organoiodine reagents as both iodine and aryl group source. 
Scheme 2. Plausible Conformations of Intermediates for Stereoselectivity of the Reaction 
 
Organoiodine(III) compounds are usually used as oxidants and electrophilic reagents where only 
one ligand of iodine(III) is removed by the substrate or replacement of both ligands with external 
nucleophile followed by its decomposition into radicals12,15,16 However, sequential removal of two ligands 
from the iodine(III) reagent by active C-H bond of substrate and incorporation of iodobenzene into the same 
substrate would indubitably make the reactions atom economic, but such organic transformations are not 
much explored.9 On the other hand, compared with known aminohalogenation of alkynes, this multiple-site 
functionalization would be of great importance to produce synthetically potential halogenated enamines in 
a stereoselective manner. The high stereoselectivity of the reaction can be explained based on the structure 
of the possible intermediates. The conformations of intermediates are controlled by the hydrogen bonding, 
steric hindrance and electrostatic attractions as shown in scheme 2. These type of interactions have never 
been explored for stereoselective alkyne aminohalogenation. Herein we report the first example of a highly 
stereoselective multiple-site functionalization of activated alkynes with amines and organoiodine(III) 
(Scheme 1c) as the halo and aryl group source for haloenamines. We have also successfully employed these 
relatively inactive 3° enamines in intramolecular cyclizations via Pd catalyzed C-H and C-I activation 
resulting in highly functionalized indoles.     
Table 1. Optimization reaction of Aminohalogenation of Alkynesa  
 
entry iodine(III) (equiv) base (equiv) solvent yield (%)b 
1 PIDA (1.5) ----- DCE 30 
2 PIDA (1.5) ----- DCE 31c 
3 PIDA (1.5) ----- DCE 0d 
4 PIDA (1.5) ----- DCE 0e 
5 PIDA (1.5) Cs2CO3 (1.0) DCE 60 
6 PIDA (1.5) Cs2CO3 (1.5) DCE 67 
7 PIDA (1.5) K2CO3 (1.5) DCE 50 
8 PIDA (1.5) K3PO4 (1.5) DCE 36 
9 PIDA (1.5) NaHCO3 (1.5) DCE 52 
10 PIDA (1.5) Na2CO3 (1.5) DCE 46 
11 PIDA (1.5) DABCO (1.5) DCE ND 
12 PIDA (1.3) Cs2CO3 (1.5) DCE 55 
13 PIDA (2.0) Cs2CO3 (1.5) DCE 73 
14 PIDA (2.5) Cs2CO3 (1.5) DCE 84 
16 PIDA (2.5) Cs2CO3 (2.0) DCE 84  
17 PIDA (1.8) Cs2CO3 (1.5) DCE 71 
18 PIDA (2.5) Cs2CO3 (1.5) DCM 54 
19 PIDA (2.5) Cs2CO3 (1.5) MeCN 61 
20 PIDA (2.5) Cs2CO3 (1.5) THF ND 
21 PIDA (2.5) Cs2CO3 (1.5) H2O 21 
22 PIDA (2.5) Cs2CO3 (1.5) EtOAc 30 
23 PIDA (2.5) Cs2CO3 (1.5) DMF 17 
24 PIFA (2.5) Cs2CO3 (1.5) DCE ND 
25 PhIO (2.5) Cs2CO3 (1.5) DCE ND 
26 PhI(OH)(OTs) 
(2.5) 
Cs2CO3 (1.5) DCE ND 
 
 
aReaction conditions: Alkyne 1a (1 mmol), Amine 2a (1 mmol), PIDA 3a (2.5 mmol), Base, dry solvent 3 mL,  
rt (27 oC) for 8-18 h; bIsolated yield after silica column chromatography; c Na2SO4 (4 equiv); d TBAI (2 equiv); e NBS 
(2 equiv); ND = Not detected.   
Results and discussion  
We choose diethyl acetylenedicarboxylate 1a, aniline 2a and phenyliodine(III) diacetate (PIDA) 3a as the 
model substrates to initiates our studies. At the beginning, the reaction was performed at room temperature 
in dichloromethane (DCE). To our delight, we observed the formation of desired product 4aaa in 31% yield 
with (Z)-configuration (Table 1, entry 1). The structure and stereochemistry of 4aaa was determined by the 
X-ray crystallography analysis (Supporting information, SI). With this promising result in hand, we further 
optimized the reaction conditions. When reaction was carried out in the presence of 4 equiv of Na2SO4 as 
additive, the product 4aaa was yielded in 31 % after 18 h reaction time (Table 1, entry 2). No product was 
obtained when the reaction was performed with TBAI and NBS as additives (entries 3&4). We then turned 
our attention to the screening of bases to improve the reaction performance. When reaction performed with 
Cs2CO3 pleasingly, the product 4aaa was obtained in 67% yield in 12 h (entries 5&6). Other bases such as 
K2CO3, K3PO4, NaHCO3, Na2CO3, and DABCO did not improve the yield of the product (entries 7-11). 
We then screened the equivalents of PIDA and Cs2CO3 (entries 12-17), 1.5 equiv of Cs2CO3 and 2.5 equiv 
of PIDA were found to be the best conditions to afford the product 4aaa in 84 % yield after 8 h (entry 14). 
Among the solvents tested, DCE was found to be the best solvent choice (entries 18-23). In our attempts to 
further improve the yield, we have screened other organoiodine sources, unfortunately our attempts went 
in vain (entries 24-26). 
In order to realize the versatility of this newly developed method, we anticipated to apply it to a 
series of amines having neutral, electron donating and withdrawing substituents on phenyl ring. This results 
demonstrated that the substrates containing neutral and electron donating groups on phenyl ring afforded 
the products (Table 2(A)) in good to very good yield. The weak electron withdrawing substituents on phenyl 
ring resulted in relatively low yields (Table 2(B)). Presence of both weak electron withdrawing and 
donating groups on the same phenyl ring gave the products fairly in good yields (Table 2, 4fab & 4maa). 
Organoiodine with strong electron withdrawing groups (-CO2Me, NO2) gave the products in excellent 
yields (Table 2(C)), this may be due to stabilization of intermediate V (Scheme 5). It is worth to mention 
here that, the robustness of our strategy is demonstrated by the synthesis of derivatives (Table 2 (D), 4a”aa 
& 4a”ab) involving formation of four new C-N bonds and two C-I bonds in single step. After developing 
successful syntheses of halogenated enamines, we envisaged that it would be appropriate to check the 
scalability of our protocol for the synthesis halogenated enamines owing to their synthetic utility. 
Accordingly, we performed the reaction on gram scale for the synthesis of halogenated enamine resulted in 
72% yield (Table 2, 4aaa).  
Table 2. Substrate Scope of Aminoiodination Reactiona 
 
 aReaction conditions: Alkyne 1a (1 mmol), Amine 2a (1 mmol), PIDA 3a (2.5 mmol), Cs2CO3 (1.5 mmol), dry DCE  
3 mL, rt (27 o C) for 8-14 h; bIsolated yield after silica column chromatography. 
Owing to the importance of halogenated enamines as flexible building blocks in organic synthesis, 
we envisioned to employ them in organic transformations. In this direction, we thought to perform 
transition-metal catalyzed intramolecular cyclizations by C-I and (sp2)C-H activation. However, less 
reactive 3° enamines than 2° enamine homologues in transition-metal catalyzed C-H activation reactions 
are scarce17 and poses a daunting challenge. The conversion of such enamines to indoles was accomplished 
by improving the electrophilicity of Pd catalysts under acidic conditions.18 
Herein we delighted to employ these iodinated enamines for smooth transformation to N-aryl 
indoles via palladium-catalyzed intramolecular cyclization under non-acidic conditions. It was noted that 
iodinated enamines containing weak electron withdrawing and electron donating groups on phenyl rings 
provided the indoles with good yields than those having electron-withdrawing groups (Scheme 3).   
Scheme 3. N-aryl Indole Synthesis from Iodinated Enamines via Pd-Catalyzed Intramolecular 
Cyclizaitona   
 
aReaction conditions: Iodoenamine 4 (1 mmol), Pd(OAc)2 (10% mol), Cu(OAc)2 (1.2 mmol), Cs2CO3 (1.5 mmol), dry DMF 1.5 
mL, at 120 o C for 20 h. bIsolated yield after silica column chromatography. c Ratio estimated by H1 NMR.    
To investigate the reaction mechanism, we performed couple of control experiments (Scheme 4). 
The addition of TEMPO uninhibited the formation of 4aaa (Scheme 4(i)), suggesting that reaction might 
proceed through ionic pathway. To further rule out the radical pathway, we performed a radical clock 
experiment under standard conditions, which afforded only the halogenated enamine product 4rab and no 
other ring-opened coupling products (Scheme 4(ii)).    
 
Scheme 4. Control Experiments  
 
Based on the above experiments and literature reports9 we have formulated the following plausible 
mechanism (scheme 5). The intermolecular reaction of 1a and 2a generates hydroamination product I 
which undergo ligand exchange with PIDA by the loss of acetic acid to give intermediate II, which would 
further transformed to intermediate (IV) by the loss of one more acetic acid, which followed by subsequent 
rearrangement leads to the formation of a zwitterion (V) which then afford the final product 4aaa.   
Scheme 5. Plausible Mechanism for Aminohalogenation of Alkynes    
 
 
In summary, we have developed a novel and facile approach for the stereoselective alkyne 
aminoiodination using amines, phenyliodine(III) diacetate (PIDA) as iodide and aryl moiety source as well 
as promoter. The key feature of this reaction is the incorporation of iodide and aryl group concurrently in 
the same molecule in a stereoselective manner. The advantages of this method are metal-free, mild reaction 
conditions and scalability. We have also successfully employed these inactive iodinated 3° enamines in 
intramolecular cyclizations via Pd catalyzed C-H and C-I activation resulting in highly functionalized 
indoles. Further exploration of iodinated 3° enamines are currently under way in our laboratory.    
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Experimental Section  
General Considerations: IR spectra were recorded on a FTIR spectrophotometer. 1H NMR spectra were 
recorded on 400 MHz spectrometer at 295 K in CDCl3; chemical shifts (δ ppm) and coupling constants 
(Hz) are reported in standard fashion with reference to either internal standard tetramethylsilane (TMS) (δH 
= 0.00 ppm) or CHCl3 (δH = 7.25 ppm). 13C NMR spectra were recorded on 100 MHz spectrometer at 25 
°C in CDCl3; chemical shifts (δ ppm) are reported relative to CHCl3 [δC = 77.00 ppm (central line of triplet)]. 
In the 1HNMR, the following abbreviations were used throughout: s = singlet, d = doublet, t = triplet, q = 
quartet, qui = quintet, dd = doublet of doublets, m = multiplet and br s. = broad singlet. The assignment of 
signals was confirmed by 1H, 13C CPD, and DEPT spectra. High-resolution mass spectra (HR-MS) were 
recorded using Q-TOF multimode source. Melting points were determined on an electrothermal melting 
point apparatus and are uncorrected. Hypervalent iodine reagents phenyliodine bis(trifluoroacetate) (PIFA) 
and phenyliodine diacetate (PIDA) were purchased from Sigma Aldrich. Other reagents were purchased as 
reagent grade and used without further purification. All dry solvents were used. CH3CN and DCE were 
dried over CaH2, DCM & DMF were dried over anhydrous P2O5, and ethyl acetate (EtOAc) was dried over 
Na2CO3 and distilled before use. 
All small scale dry reactions were carried out using standard syringe-septum technique. Reactions were 
monitored by TLC on silica gel using a combination of petroleum ether and ethyl acetate as eluents. All 
reactions were performed under air atmosphere in standard glassware, heated at 80 °C for 3 h before use. 
Solvents were distilled prior to use; petroleum ether with a boiling range of 40 to 60 °C was used. Organic 
solutions were concentrated by rotary evaporation under vacuum. Acme’s silica gel (60–120 mesh) was 
used for column chromatography (approximately 20 g per one gram of crude material). 
1. General Procedure-I for Aminoiodination of Alkynes Using Synthesis of 4aaa as an Example.  
Aniline 1a (50 mg, 1 mmol) was taken in a dried round bottom flask, and dialkyl acetylenedicarboxylate 
2a (91.3 mg,  1 mmol) was then added slowly with thorough mixing to form a homogeneous paste, then 
add 0.5 mL DCE solvent (if required). After confirming the formation of enamine (monitored by TLC), 
then added 4 mL DCE solvent, followed by addition of Cs2CO3 (261.959 mg, 1.5 mmol), phenyliodine(III) 
diacetate (PIDA) 3a (431.614 mg, 2.5 mmol) in portion wise for 20 min. The progress of the reaction was 
monitored by TLC. The reaction mixture was quenched by addition of saturated solution of NaHCO3 and 
extracted with ethyl acetate (EtOAc), dried over MgSO4, and concentrated in vacuo. The residue was 
purified through a silica gel column chromatography using petroleum ether/ethyl acetate (0.2/9.8) as eluent 
to yield (209 mg, 84%). All compounds (4aaa-4rab) were unknown and confirmed by FTIR, 1H NMR, 13C 
NMR and HR-MS spectral analyses.         
2. General Procedure-II for Aminoiodination of Alkyne Using   Synthesis of 4a”aa as an Example. 
p-Phenylenediamine 1a” (50 mg, 1 mmol) was taken in a dried round bottom flask, and dialkyl 
acetylenedicarboxylate 2a (157.35 mg,  2 mmol) was then added slowly with thorough mixing to form a 
homogeneous paste, then add 2 mL DCE solvent (if required). After confirming the formation of enamine 
(monitored by TLC), then added 8 mL DCE solvent, followed by addition of Cs2CO3 (451.58 mg, 3.0 
mmol), phenyliodine(III) diacetate (PIDA) 3a (744.05 mg, 5.0 mmol) in portion wise for 20 min. The 
progress of the reaction was monitored by TLC. The reaction mixture was quenched by addition of saturated 
solution of NaHCO3 and extracted with ethyl acetate (EtOAc), dried over MgSO4, and concentrated in 
vacuo. The residue was purified through a silica gel column chromatography using petroleum ether/ethyl 
acetate (0.2/9.8) as eluent to yield (212.55 mg, 54%). Compounds 4a”aa and 4a”ab were unknown and 
confirmed by FTIR, 1H NMR, 13C NMR and HR-MS spectral analyses.         
3. General Procedure-III for the Synthesis of N-Aryl Indoles Using Synthesis of 5a as an Example.  
To a mixture of N-diaryl β-iodinated enamine 4a (50 mg, 1.0 mmol), Pd(OAc)2 (2.4 mg, 0.1 mmol) and 
Cu(OAc)2 (23.32 mg, 1.2 mmol) was added 1.5 mL of dry DMF in an oven dried 15 mL schlenk tube. The 
reaction mixture was stirred at 120 °C for 20 h. After cooling the reaction mixture to room temperature, 
then the reaction mixture was quenched by addition of water and extracted with ethyl acetate followed by 
water wash for two times, dried over MgSO4, and concentrated in vacuo. The residue was purified by silica 
gel column chromatography using petroleum ether/ethyl acetate (0.2/9.8) as eluent to yield N-Aryl indole 
product 5a (26.82 mg, 74%). Compounds 5a-5h were unknown and confirmed by FTIR, 1H NMR, 13C 
NMR and HR-MS spectral analyses. 
General procedure (GP-IV) for the synthesis organoiodine(III) reagents (3b, 3c & 3d)19: 
Compounds 3b, 3c and 3d were prepared according to the literature method.18 To a solution of substituted 
iodobenzene (1.0 mmol) in AcOH was added mCPBA (ca. 65%, 1.15 mmol). The mixture was stirred at 
room temperature for 2 h. Then, H2O was added to the reaction mixture and then it was extracted with 
CHCl3. After being dried over Na2SO4, filtration, and removal of the solvent Et2O and hexane were added 
to the residue, and the mixture was cooled to 0°C to induce precipitation. After filtration, the solids were 
washed with a mixture of Et2O and hexane to provide products (Diacetoxyiodo)benzene derivatives (3b, 3c 
and 3d).  
(Z)Diethyl 2-(diphenylamino)-3-iodomaleate (4aaa) 
Deep yellow solid (209 mg, 84%). m.p. = 54-56 °C  (recrystallized by placing inside the refrigerator); FR-
IR (MIR-ATR, 4000-600 cm-1): ѵmax = 3034.9, 2980.5, 2936.4, 1729.9, 1491.7, 1288.1, 1219.4, 1041.4, 
1027.6, 838.2, 756.9, 695.1;1H NMR (CDCl3, 400 MHz): δH = 7.30 (m, 4H); 7.11 (m, 6H); 4.26 (q, J = 7.2 
Hz, 2H); 4.02 (q, J = 6.8 Hz, 2H); 1.33 (t, J = 7.1 Hz, 3H); 0.96 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 
MHz): 164.3, 145.4, 144.5, 142.8, 141.8, 141.3, 133.3, 1130.5, 102.6, 63.1, 14 .1; HR-MS (ESI+) m/z value 
calculated for [C20H20INO4]+ = [M+H]+  : 466.0510; found: 466.0498. 
(Z)Dimethyl 2-(diphenylamino)-3-iodomaleate (4aab) 
Yellow oil (197 mg, 82%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 3033.1, 3006.6, 2949.9, 2849.1, 
1732.8, 1550.3, 1489.7, 1434.1, 1288.7, 1223.3, 1147.4, 1042.8, 988.8, 757.4, 695.2; 1H NMR (CDCl3, 400 
MHz): δH = 7.30 (m, 4H); 7.1 (m, 6H); 3.80 (s, 3H); 3.57 (s, 3H); 13C NMR (CDCl3, 100 MHz):  166.2, 
164.5, 149.5, 144.1, 129.3, 124.7, 124.0, 86.9, 53.5, 52.9;  HR-MS (ESI+) m/z value calculated for 
[C18H16IKNO4]+ = [M+K]+: 475.9756; found: 475.9749. 
(Z)Diethyl 2-iodo-3-(phenyl(m-tolyl)amino)maleate (4caa) 
Yellow oil (190 mg, 85%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2936.66, 1731.04, 1701.04, 1592.15, 
1503.53, 1459.87, 1421.39, 1234.69, 1206.48, 1128.33, 1008.78, 759.89, 699.87;1H NMR (CDCl3, 400 
MHz): δH = 7.26 - 7.32 (m, 2H), 7.14 - 7.19 (m, 1H), 7.10 (d, J = 6.85 Hz, 3H), 6.87 - 6.93 (m, 3H), 4.24 
(q, J = 7.17 Hz, 2H), 4.02 (q, J = 7.34 Hz, 2H), 2.29 (s, 3H), 1.31 (t, J = 7.09 Hz, 3H), 0.97 (t, J = 7.09 Hz, 
3H); 13C NMR (CDCl3, 100 MHz): 165.9, 163.9, 149.5, 144.3, 144.2, 139.1, 129.2, 129.0, 125.4, 124.6, 
124.4, 124.2, 121.2, 87.4, 62.6, 62.0, 21.4, 14.0, 13.6;  HR-MS (ESI+) m/z value calculated for 
[C21H23INO4]+ = [M+H]+: 480.0670; found: 480.0672. 
(Z)Diethyl 2-((3,5-dimethylphenyl)(phenyl)amino)-3-iodomaleate (4daa) 
Yellow oil (166 mg, 82%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2998.4, 2945.1, 2818.4, 1718.9, 
1600.3, 1500.6, 1498.4, 1419.3, 1216.5, 1200.8, 1143.4, 1100.8, 1032, 769.7, 693.2. 1H NMR (CDCl3, 400 
MHz): δH = 7.23 (d, J = 6.4 Hz, 2H); 7.07, (m, 2H); 6.97 (m, 3H); 6.83 (br, s, 1H); 4.21 (d, J = 7.3 Hz, 2H); 
3.98 (d, J = 7.3 Hz, 2H); 2.28 (s, 3H); 2.04 (s, 3H); 1.31 (t, J = 7.04 Hz, 3H); 0.96 (t, J = 7.04 Hz, 3H). 13C 
NMR (CDCl3, 100 MHz): δ = 165.8, 164.2, 151.7, 144.8, 141.2, 136.2, 133.7, 131.4, 129.0, 128.8, 127.7, 
123.9, 123.2, 80.2, 62.5, 61.9, 21.7, 20.9, 18.8, 14, 13.5;  HR-MS (ESI+) m/z value calculated for 
[C22H25INO4]+ = [M+H]+: 494.0828; found: 494.0824. 
(Z)Dimethyl 2-iodo-3-((2-isopropylphenyl)(phenyl)amino)maleate (4eab) 
Yellow oil (138 mg, 78%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2997.4, 2918.4, 1712.9, 1683.3, 
1501.6, 1496.4, 1427.3, 1215.4, 1202.6, 1133.4, 1022.4, 767.7, 694.2; 1H NMR (CDCl3, 400 MHz): δH =  
7.31 - 7.35 (m, 1H), 7.23 - 7.30 (m, 3H), 7.11 - 7.18 (m, 2H), 7.06 (t, J = 7.34 Hz, 1H), 6.94 - 7.04 (m, 1H), 
6.86 (br. s., 1H), 3.76 (s, 3H), 3.50 (s, 3H), 3.17 (sept, J = 6.85 Hz, 1H), 1.04 - 1.24 (d, 6H), 13C NMR 
(CDCl3, 100 MHz): δ =  166.0, 164.8, 152.9, 147.2, 145.5, 140.6, 129.3, 129.0, 128.0, 127.4, 126.6, 124.4, 
124.2, 53.5, 52.7, 28.0;  HR-MS (ESI+) m/z value calculated for [C22H24INO4]+ = [M+H]+: 480.0672; 
found: 480.0668. 
(Z)Dimethyl 2-((2-bromo-5-methylphenyl)(phenyl)amino)-3-iodomaleate (4fab) 
Yellow oil (110 mg, 77%); FT-IT:: (MIR-ATR,4000-600 cm-1): ѵmax = 3002.8, 2928.4, 2890.4, 1720.6, 
1555.7, 1429.7, 1420, 1230.6, 1078.9, 985.7, 760.5, 695.3; 1H NMR (CDCl3, 400 MHz): δH = 7.42 (s, 1H); 
7.22 (d, J = 7.8 Hz, 2H); 7.12 (d, J = 8.3 Hz, 3H); 7.08 (s, 1H); 7.06 (s, 1H); 3.78 (s, 3H); 3.55 (s, 3H); 2.34 
(s, 3H); 13C NMR (CDCl3, 100 MHz): δ = 166.1, 164.5, 151.2, 144.3, 139.3, 138.3, 134.7, 129.7, 129.4, 
129.1, 124.0, 123.1, 82.2, 53.5, 52.8, 20.8; HR-MS (ESI+) m/z value calculated for [C19H17BrINaNO4]+ = 
[M+Na]+ : 553.9260; found: 553.9251. 
(Z)Diethyl 2-iodo-3-((4-methoxyphenyl)(phenyl)amino)maleate (4gaa) 
Yellow oil (157 mg, 78%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2981.42, 1729.22, 1555.32, 1490.18, 
1290.53, 1227.06, 1193.16, 1043.82, 758.67, 694.93; 1H NMR (CDCl3, 400 MHz): δH = 7.24 - 7.30 (m, 
2H), 6.99 - 7.10 (m, 5H), 6.81 - 6.87 (m, 2H), 4.23 (q, J = 7.01 Hz, 2H), 4.02 (q, J = 7.34 Hz, 2H), 3.80 (s, 
3H), 1.31 (t, J = 7.09 Hz, 3H), 0.99 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 165.8, 164.1, 157.1, 
150.2, 144.8, 137.1, 129.2, 126.7, 124.0, 123.3, 114.4, 85.0, 62.6, 62.0, 55.5, 14.0, 13.6; HR-MS (ESI+) 
m/z value calculated for [C21H22IKNO5]+ = [M+K]+: 534.0174; found: 534.0192 
(Z)Dimethyl 2-iodo-3-((4-methoxyphenyl)(phenyl)amino)maleate (4gab) 
Yellow oil (152 mg, 80%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2950.15, 2837.74, 1731.23, 1546.86, 
1505.44, 1433.68, 1242.06, 1220.03, 1145.92, 1031.65, 835.86, 758.74, 693.82; 1H NMR (CDCl3, 400 
MHz): δH = 7.25 - 7.28 (m, 3H), 7.07 (d, J = 8.80 Hz, 2H), 7.01 (d, J = 7.82 Hz, 2H), 6.84 (d, J = 8.80 Hz, 
2H), 3.79 (s, 3H), 3.80 (s, 3H), 3.57 (s, 3H); 13C NMR (CDCl3, 100 MHz): 163.9, 157.2, 144.7, 137.0, 136.9, 
129.2, 126.7, 124.2, 123.4, 114.5, 55.5, 53.5, 52.8; HR-MS (ESI+) m/z value calculated for [C19H18IKNO5]+ 
= [M+K]+: 505.9860; found: 505.9868. 
(Z)Diethyl 2-iodo-3-(phenyl(3,4,5-trimethoxyphenyl)amino)maleate (4haa) 
Yellow oil (114 mg, 75%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2980.42, 1730.22, 1550.30, 1480.19, 
1295.50, 1220.16, 1193.28, 1040.76, 750.69, 681.90;1H NMR (CDCl3, 400 MHz): δH = 7.70 (d, J = 7.34 
Hz, 1H), 7.31 (t, J = 7.83 Hz, 2H), 7.11 (s, 2H), 6.32 (s, 2H), 4.25 (q, J = 7.34 Hz, 2H), 4.05 (q, J = 7.34 
Hz, 2H), 3.83 (s, 3H), 3.75 (s, 6H), 1.32 (t, J = 7.09 Hz, 3H), 1.01 (t, J = 7.34 Hz, 3H); 13C NMR (CDCl3, 
100 MHz): 165.8, 164.0, 153.6, 149.5, 144.1, 140.1, 137.5, 135.3, 130.3, 129.2, 127.5, 124.5, 124.1, 101.8, 
87.2, 62.7, 62.1, 61.0, 56.2, 13.9, 13.6; HR-MS (ESI+) m/z value calculated for [C23H26INaNO4]+ = 
[M+Na]+: 578.0650; found: 578.0652. 
(Z)Dimethyl 2-((2-fluorophenyl)(phenyl)amino)-3-iodomaleate (4iab) 
Yellow oil; (180 mg, 88%); FT-IR: (MIR-ATR,4000-600 cm-1): ѵmax =  2951.5, 1990.1, 1731.9, 1590.7, 
1497.3, 1434.2, 1299.9, 1230.6, 1043.2, 988.9, 757.4, 695.0:1H NMR (CDCl3, 400 MHz): δH = 7.27 (m, 
4H); 7.12 (m, 3H); 6.97 (d, J = 7.8 Hz, 2H); 3.80 (s, 3H); 3.58 (s, 3H); 13C NMR (CDCl3, 100 MHz): δ = 
166.1, 164.1, 158.9, 156.4, 149.5, 136.4, 129.2, 124.95, 124.43, 121.77, 117.0, 116.8, 86.02, 53.56, 52.94; 
HR-MS(ESI+) m/z value calculated for [C18H16FINO4]+ = [M+H]+ : 456.0103; found: 456.0096.  
(Z)Diethyl 2-((4-chlorophenyl)(phenyl)amino)-3-iodomaleate (4jaa) 
Yellow oil (167 mg,  85%);  FT-IR: (MIR-ATR, 4000-600cm-1): ѵmax = 2980.5, 2926.9, 2850.7, 1725.5, 
1586.9, 1554.1, 1486.6, 1366.3, 1283.9, 1213.8, 1147.2, 1091.3, 1040.8, 823.6, 758.3, 695.5;  1H NMR 
(CDCl3, 400 MHz): δH =  7.23 - 7.32 (m, 4H), 7.01 - 7.14 (m, 5H), 4.22 - 4.29 (q, J = 7.34 Hz, 2H), 4.03 
(q, J = 7.34 Hz, 2H), 1.29 - 1.34 (t, J = 7.09, 3H), 1.00 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 
δ = 165.7, 163.6, 148.6, 143.9, 142.9, 129.5, 129.4, 124.8, 123.8, 89.7, 62.8, 62.2, 13.9, 13.6; HR-MS 
(ESI+) m/z calculated for [C20H20ClINO4]+ = [M+H]+: 500.0126; found: 500.0139. 
(Z)Diethyl 2-((4-bromophenyl)(phenyl)amino)-3-iodomaleate (4kaa) 
Yellow oil (140 mg, 88%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2890.20, 1730.71, 1520.35, 1461.81, 
1368.26, 1294.03, 1229.20, 1175.10, 1020.22, 754.92, 605.23; 1H NMR (CDCl3, 400 MHz): δH = 7.36 - 
7.42 (m, 2H), 7.27 - 7.32 (m, 2H), 7.07 - 7.14 (m, 3H), 6.94 - 7.00 (m, 2H), 4.26 (q, J = 7.17 Hz, 2H), 4.04 
(q, J = 6.85 Hz, 2H), 1.32 (t, J = 7.09 Hz, 3H), 1.00 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 
165.7, 163.5, 148.4, 143.8, 143.4, 132.3, 129.4, 125.1, 124.8, 123.8, 117.1, 90.2, 62.8, 62.2, 13.9, 13.6; 
HR-MS (ESI+) m/z value calculated for [C20H20BrINO4]+ = [M+H]+: 547.9650; found: 547.9652. 
(Z)Dimethyl 2-((4-bromophenyl)(phenyl)amino)-3-iodomaleate (4kab) 
Yellow oil (125 mg, 83%); FT-IR(MIR-ATR, 4000-600 cm-1): ѵmax = 2951.6, 2923.2, 2851.3, 1729.9, 
1552.4, 1485.4, 1433.2, 1219.9, 1146.6, 1043, 986.7, 816, 733, 695; 1H NMR (CDCl3, 400 MHz): δH = 
7.40 (d, J = 8.8 Hz, 2H); 7.31 (m, 2H); 7.13 (s, 1H); 7.08 (d, J = 7.8 Hz, 2H); 6.96 (d, J = 8.8 Hz, 2H); 3.81 
(s, 3H); 3.59 (s, 3H); 13C NMR (CDCl3, 100 MHz): δ = 166.1, 164.1, 148.6, 143.7, 143.3, 132.4, 129.4, 
125.1, 124.9, 123.9, 117.3, 88.9, 53.6, 53.0; HR-MS (ESI+) m/z value calculated for [C18H15BrINO4]+ = 
[M+K]+: 514.9229; found: 514.9225. 
(Z)Diethyl 2-((2-bromophenyl)(phenyl)amino)-3-iodomaleate (4laa) 
Yellow oil (126 mg, 79%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2892.21, 1720.74, 1527.45, 1471.88, 
1368.26, 1294.03, 1219.26, 1176.16, 1026.28, 754.92, 604.33;1H NMR (CDCl3, 400 MHz): δH = 7.57 - 
7.61 (m, 1H), 7.31 - 7.37 (m, 2H), 7.21 - 7.30 (m, 2H), 6.98 - 7.15 (m, 3H), 6.75 (br. s., 1H), 4.23 (q, J = 
6.85 Hz, 2H), 4.00 (q, J = 6.85 Hz, 2H), 1.30 (t, J = 7.09 Hz, 3H), 0.97 (t, J = 7.09 Hz, 3H); 13C NMR 
(CDCl3, 100 MHz): 165.7, 163.8, 150.6, 144.3, 142.1, 134.4, 129.8, 129.1, 128.6, 127.7, 124.3, 123.3, 85.0, 
62.6, 62.0, 13.9, 13.5; HR-MS (ESI+) m/z value calculated for [C20H20BrINO4]+ = [M+H]+: 547.9655; 
found: 547.9656 
(Z)Diethyl 2-iodo-3-((2-methyl-3-nitrophenyl)(phenyl)amino)maleate (4maa) 
Yellow oil (129 mg, 75%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 3018, 2949.9, 1707, 1550.3, 1350, 
1288.7, 1199, 1074, 731, 695.2; 1H NMR (CDCl3, 400 MHz): δH = 7.72 (d, J = 7.83 Hz, 1H), 7.51 (d, J = 
7.82 Hz, 1H), 7.36 (t, J = 8.07 Hz, 1H), 7.27 (s, 2H), 7.08 - 7.14 (m, 1H), 7.01 (br. s., 1H), 6.76 (br. s., 1H), 
4.24 (q, J = 7.34 Hz, 2H), 4.02 (q, J = 7.01 Hz, 2H), 2.21 (s, 3H), 1.32 (t, J = 7.09 Hz, 3H), 0.99 (t,  J = 
7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 165.4, 163.6, 152.0, 150.5, 144.4, 137.5, 131.9, 130.9, 129.5, 
127.3, 126.8, 124.8, 122.0, 85.6, 77.4, 77.1, 76.7, 62.8, 62.3, 15.9, 13.9, 13.5; HR-MS (ESI+) m/z value 
calculated for [C21H21IN2NaO6]+ = [M+Na]+: 547.0342; found: 547.0322. 
(Z)Diethyl 2-iodo-3-((4-(methoxycarbonyl)phenyl)(phenyl)amino)maleate (4aba) 
Yellow oil (252 mg, 90%); FT-IR : (MIR-ATR, 4000-600 cm-1): ѵmax = 2982.2, 2952.2, 1714.8, 1590.5, 
1506.7, 1489.8, 1434.6, 1366.6, 1271.9, 1216.4, 1175.6, 1106.7, 1039.5, 767.5, 695.5; 1H NMR (CDCl3, 
400 MHz): δH = 7.96 (d, J = 8.8 Hz, 2H); 7.34 (m, 2H); 7.17 (m, 3H); 7.07 (d, J = 8.3 Hz, 2H); 4.29 (q, J = 
7.2 Hz, 2H); 4.05 (q, J = 6.8 Hz, 2H); 3.89 (s, 3H); 1.35 (t, J = 7.3 Hz, 3H); 1.01 (t, J = 7.3 Hz, 3H); 13C 
NMR (CDCl3, 100 MHz): 166.6, 165.7, 163.1, 148.5,  147.2, 143.1, 131.0, 129.5, 125.5, 124.8, 124.7, 
121.2, 93.7, 62.8, 62.3, 52.0, 13.9, 13.6; HR-MS (ESI+) m/z value calculated for [C22H22INaNO6]+ = 
[M+Na]+: 523.0492; found: 523.0488.   
(Z)Dimethyl 2-iodo-3-((4-(methoxycarbonyl)phenyl)(phenyl)amino)maleate (4abb) 
Yellow oil (231 mg, 87%); FR-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 3001.0, 2951.4, 2842.4, 1713.4, 
1589.6, 1489.4, 1432.9, 1271.4, 1217.8, 1104.8, 1039.7, 800.8, 760.9, 695.6; 1H NMR (CDCl3,  400 MHz): 
δH = 7.96 (d, J = 8.8 Hz, 2H); 7.34 (m, 2H); 7.18 (d, J = 8.3 Hz, 3H); 7.05 (d, J = 8.8 Hz, 2H); 3.89 (s, 3H); 
3.84 (s, 3H); 3.6 (s, 3H);13C NMR (CDCl3, 100 MHz): 166.6, 166.1, 163.8, 148.3, 147.5, 142.9, 131.1, 
129.6, 125.6, 124.9, 124.7, 121.2,  92.7, 53.6, 53.0, 52.0; HR-MS (ESI+) m/z value calculated for 
[C20H18IKNO6]+ = [M+K)]+[H20] :515.9705; found : 515.9703.  
(Z)Dimethyl 2-iodo-3-((4-(methoxycarbonyl)phenyl)(4-methoxyphenyl)amino)maleate (4gbb) 
Yellow oil (164 mg, 77%); FT-IR (MIR-ATR, 4000-600 cm-1) ѵmax = 2952.1, 2924.2, 2851.7, 1719.9, 
1605.7, 1506.6, 1434.1, 1277.0, 1245.4, 1176.7, 1109.6, 1035.7, 838.2, 769.1, 696.9; 1H NMR (CDCl3, 400 
MHz): δH = 7.93 (d, J = 8.8 Hz, 2H); 7.14 (d, J = 8.8 Hz, 2H); 6.96 (d, J = 8.8 Hz, 2H); 6.88 (d, J = 8.8 Hz, 
2H); 3.89 (s, 3H); 3.82 (s, 3H); 3.61 (s, 3H); 13C NMR (CDCl3, 100 MHz): 166.6, 166.0, 164.0, 157.8, 
148.8, 148.1, 135.5, 131.0, 127.3, 124.4, 120.0, 114.7, 90.3, 55.5, 53.6, 53.0, 52.0; HR-MS (ESI+) m/z 
value calculated for [C21H22INO7]+ = [M+H]+: 525.0284; found: 525.0280.  
(Z)Dimethyl 2-((4-bromophenyl)(4-(methoxycarbonyl)phenyl)amino)-3-iodomaleate (4kbb) 
Yellow oil (152 mg, 91%); FT-IR (MIR-ATR, 4000-600 cm-1) ѵmax = 3000.51, 2950.90, 2838.30, 1715.90, 
1595.42, 1498.90, 1423.12, 1270.81, 1222.7, 1094.96, 1049.98, 976.85, 819.89, 769.51, 685.30;1H NMR 
(CDCl3, 400 MHz): δH = 7.96 (d, J = 8.80 Hz, 2H), 7.46 (d, J = 8.80 Hz, 2H), 7.04 (d, J = 8.31 Hz, 4H), 
3.90 (s, 3H), 3.84 (s, 3H), 3.62 (s, 3H); 13C NMR (CDCl3, 100 MHz): 166.5, 165.9, 163.5, 147.9, 146.7, 
142.1, 132.7, 131.8, 131.2, 126.0, 125.3, 121.2, 118.5, 116.2, 94.1, 53.7, 53.2, 52.1, 29.7; HR-MS (ESI+) 
m/z value calculated for [C20H17BrIKNO6]+ = [M+K]+: 611.8920; found: 611.8921. 
(Z)Diethyl 2-((2-bromo-5-methylphenyl(4-(methoxycarbonyl)phenyl)amino-3-iodomaleate (4nba) 
Yellow oil (136 mg, 86%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2981.3, 2951.9, 1714.3, 1606.8, 
1565, 1486.9, 1434.4, 1275, 1215.6, 1104.8, 1014.3, 850.3, 768.5, 735.2, 696.5; 1H NMR (CDCl3, 400 
MHz): δH = 7.93 (m, 2H); 7.45 (s, 1H); 7.24 (s, 1H); 7.18 (s, 1H); 6.95 (br, s, 1H); 6.74 (br, s, 1H); 4.25 (q, 
J = 7.3 Hz, 2H); 4.03 (q, J = 6.8 Hz, 2H); 3.88 (s, 3H); 2.36 (s, 3H); 1.32 (t, J = 7.1 Hz, 3H); 1.02 (t, J = 
7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ = 166.6, 165.6, 163.5, 149.0, 148.4, 138.7, 138.3, 134.8, 
130.8, 129.7, 129.3, 124.8, 123.0, 89.3, 67.1, 62.8, 62.3, 52.0, 20.8, 13.9, 13.6; HR-MS (ESI+) m/z value 
calculated for [C23H23BrINO6]+ = [M+H]+: 614.9753; found: 614.9749.  
(Z)Diethyl 2-iodo-3-((3-nitrophenyl)(phenyl)amino)maleate (4aca) 
Yellow oil (218 mg, 84%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 3006.1, 2944.9, 1732.9, 1558.3, 
1499.7, 1444.1, 1288.7, 1144.4, 1032.8, 968.8, 747.4, 665.4; 1H NMR (CDCl3, 400 MHz): δH = 7.88 - 7.93 
(m, 2 H), 7.43 - 7.48 (m, 1 H), 7.33 - 7.39 (m, 3 H), 7.14 - 7.22 (m, 3 H), 4.29 (q, J=7.34 Hz, 2 H), 4.06 (q, 
J=7.34 Hz, 2 H), 1.34 (t, J=7.09 Hz, 3 H), 1.01 (t, J=7.09 Hz, 3 H); 13C NMR (CDCl3, 100 MHz): 165.5, 
163.0, 149.2, 147.2, 145.7, 142.9, 130.1, 129.7, 127.9, 125.7, 124.2, 118.2, 117.0, 93.8, 63.0, 62.4, 13.9, 
13.6; HR-MS (ESI+) m/z value calculated for [C20H19IN2NaO6]+ = [M+Na]+: 533.0185; found: 533.0188. 
(Z)Dimethyl 2-((4-fluorophenyl)(phenyl)maleate)-3-iodomaleate (4adb) 
Yellow oil (220 mg, 90%); FT-IR: (MIR-ATR, 400-600 cm-1): ѵmax = 2952.9, 2916.2, 2849.7, 1730.8, 
1678.8, 1551.7, 1502.6, 1216.4, 1148.9, 616.8; 1H NMR (CDCl3, 400 MHz): δH= 7.29 (m, 2H); 7.09 (m, 
3H); 7.02 (m, 4H); 3.80 (s, 3H); 3.58 (s, 3H); 13C NMR (CDCl3, 100 MHz): δ = 166.1, 164.4, 161.1, 158.7, 
149.6, 144.3 129.4 126.2, 124.6, 123.5, 116.3, 116.1, 86.5, 53.6, 53.9; HR-MS (ESI+) m/z value calculated 
for [C18H15FINO4]+ = (M+NH4)+[-H2O]: 455.0262; found: 455.0255. 
(Z)Dimethyl 2-((2,4-dimethylphenyl)(4-fluorophenyl)amino)-3-iodomaleate (4oda) 
Yellow oil (173 mg, 87%); FT-IR: (MIR-ATR, 4000-600 cm-1): ѵmax = 2918.74, 2850.71, 1733.96, 1543.47, 
1502.20, 1212.56, 1045.19, 966.76, 828.20, 734.06; 1H NMR (CDCl3, 400 MHz): δH = 6.79 - 7.06  
(m, 7 H), 4.20 (q, J = 6.85 Hz, 2H), 3.99 (q, J = 7.34 Hz, 2H), 2.31 (s, 3H), 2.06 (s, 3H), 1.29 (t, J = 7.09 
Hz, 3H), 1.00 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 165.6, 164.2, 160.5, 158.1, 151.9, 141.1, 
141.0, 139.4, 136.8, 135.9, 132.3, 128.1, 127.8, 124.9, 124.8, 115.9, 115.7, 79.4, 62.6, 62.0, 21.0, 19.0, 
14.0, 13.6; HR-MS (ESI+) m/z value calculated for [C22H23FINO4]+ = [M+H]+: 514.0789; found: 514.0784. 
(Z)Diethyl 2-(butyl(phenyl)amino)-3-iodomaleate (4paa) 
Yellow oil (216 mg, 71%); FT-IR (MIR-ATR, 4000-600 cm-1) ѵmax = 3002.1, 2951.7, 1724.9, 1610.7, 
1516.6, 1424.1, 1247.0, 1228.4, 1173.7, 1033.7, 832.2, 767.1, 691.9; 1H NMR (CDCl3, 400 MHz): δH = 
7.24 - 7.31 (m, 2H), 6.92 - 7.00 (m, 3H), 4.21 (dq, J = 17.61, 7.17 Hz, 4H), 3.51 - 3.62 (m, 2H), 1.66 - 1.76 
(m, 2H), 1.35 - 1.41 (m, 2H), 1.31 (t, J = 7.09 Hz, 3H), 1.20 (t, J = 7.09 Hz, 3H), 0.95 (t, J = 7.34 Hz, 3H); 
13C NMR (CDCl3, 100 MHz): 165.7, 164.2, 151.1, 145.1, 137.5, 129.2, 122.7, 122.3, 119.9, 85.0, 77.4, 77.1, 
76.8, 62.5, 62.1, 52.3, 31.1, 20.2, 14.0, 13.9, 13.8; HR-MS (ESI+) m/z value calculated for 
[C18H24INNaO4]+ = [M+Na]+: 468.0648; found: 468.0644. 
(Z)Diethyl 2-(benzyl(phenyl)amino)-3-iodomaleate (4qaa) 
Yellow oil (168 mg, 75%); FT-IR (MIR-ATR, 4000-600 cm-1) ѵmax = 3062.2, 3030, 2949.92, 1730.9, 
1699.3, 1621.9, 1540.1, 1241.4, 1030.4, 998.0, 808.4, 730.44, 696.07; 1H NMR (CDCl3, 400 MHz): δH = 
7.42 (d, J = 7.34 Hz, 2H), 7.33 (t, J = 7.58 Hz, 2H), 7.20 - 7.26 (m, 3H), 6.93 - 6.99 (m, 3H), 4.82 (s, 2H), 
4.23 (q, J = 6.85 Hz, 2H), 4.14 (q, J = 7.34 Hz, 2H), 1.31 (t, J = 7.09 Hz, 3H), 1.13 (t, J = 7.09 Hz, 3H); 
13C NMR (CDCl3, 100 MHz): 165.7, 164.1, 151.1, 145.5, 137.8, 129.1, 128.5, 127.3, 127.2, 122.6, 120.3, 
62.6, 62.2, 56.6, 13.9, 13.7; HR-MS (ESI+) m/z value calculated for [C21H23INO4]+ = [M+H]+: 480.0670; 
found: 480.0672. 
(Z)Dimethyl 2-(cyclopropyl(phenyl)amino)-3-iodomaleate (4rab) 
Yellow oil (239 mg, 68%); FT-IR (MIR-ATR, 4000-600 cm-1) ѵmax = 2988.1, 2924.0, 1726.4, 1645.6, 
1501.6, 1444.1, 1287.4, 1245.4, 1103.6, 1035.7, 818.2, 734.2, 636.3; 1H NMR (CDCl3, 400 MHz): δH = 
7.25 - 7.31 (m, 2H), 7.05 (d, J = 7.83 Hz, 2H), 6.95 (t, J = 7.34 Hz, 1H), 3.85 (s, 3H), 3.71 (s, 3H), 2.86 - 
2.92 (m, 1H), 0.85 - 0.91 (m, 4H); 13C NMR (CDCl3, 100 MHz): 164.6, 163.7, 145.0, 129.2, 121.0, 116.2, 
96.7, 53.5, 53.0, 32.2, 8.6; HR-MS (ESI+) m/z value calculated for [C15H16IKNO4]+ = [M+K]+: 439.9760; 
found: 439.9761. 
(Z)Tetraethyl 3,3'-(1,4-phenylenebis(phenylmethylene))bis(2-iodomaleate) (4a”aa) 
Yellow oil (212 mg, 54%); FT-IR (MIR-ATR, 4000-600 cm-1) ѵmax = 2952, 2853.9, 1737.7, 1695.7, 1536.6, 
1438.1, 1345.4, 1186.7, 1015.7, 828.4, 769.3, 676.2; 1H NMR (CDCl3, 400 MHz): δH = 7.25 - 7.33  
(m, 6H), 7.05 - 7.10 (m, 8H), 4.25 (q, J = 7.01 Hz, 4H), 4.04 (q, J = 6.85 Hz, 4H), 1.32 (t, J = 7.34 Hz, 6H), 
1.02 (t, J = 7.09 Hz, 6H); 13C NMR (CDCl3, 100 MHz): 165.8, 163.8, 149.2, 144.2, 140.7, 129.3, 125.2, 
124.5, 123.5, 88.2, 62.7, 62.1, 13.9, 13.7; HR-MS (ESI+) m/z value calculated for [C34H35I2N2O8]+ = 
[M+H]+: 853.0480; found: 853.0483. 
(Z)Tetramethyl 3,3'-(1,4-phenylenebis(phenylmethylene))bis(2-iodomaleate) (4a”ab) 
Yellow oil (225 mg, 61%); FT-IR (MIR-ATR, 4000-600 cm-1) ѵmax = 2953.2, 2948, 1709, 1688, 1508.4, 
1495.3, 1434.2, 1214.3, 1183, 1119.4, 1032.7, 752.4, 691.5; 1H NMR (CDCl3, 400 MHz): δH = 7.27 - 7.33 
(m, 4H), 7.06 - 7.14 (m, 6H), 7.04 (s, 4H), 3.80 (s, 6H), 3.59 (s, 6H); 13C NMR (CDCl3, 100 MHz): 166.1, 
164.4, 149.5, 143.9, 140.7, 129.4, 125.2, 124.8, 123.6, 86.9, 53.6, 53.0 ; HR-MS (ESI+) m/z value 
calculated for [C30H27I2N2O8]+ = [M+H]+: 796.9855; found: 796.9857. 
 
Diethyl 1-phenyl-1H-indole-2,3-dicarboxylate (5a) 
 
Yellow liquid (29 mg, 81%); FT-IR (MIR-ATR, 4000–600 cm-1) νmax = 2950, 1737, 1707, 1539, 1501, 
1451, 1437, 1257, 1208, 1178, 1063, 788, 755, 718; 1H NMR (CDCl3, 400 MHz): δH = 8.15 (d, J = 6.85 
Hz, 1H), 7.41 - 7.48 (m, 3H), 7.33 - 7.37 (m, 2H), 7.18 - 7.26 (m, 2H), 7.10 - 7.14 (m, 1H), 4.35 (q, J = 
7.34 Hz, 2H), 4.16 (q, J = 7.01 Hz, 2H), 1.35 (t, J = 7.09 Hz, 3H), 1.05 (t, J = 7.09 Hz, 3H); 13C NMR 
(CDCl3, 100 MHz): 164.0, 162.4, 137.3, 136.5, 136.3, 129.6, 129.0, 127.3, 125.3, 124.6, 123.0, 122.3, 
111.2, 108.3, 62.1, 60.4, 14.4, 13.8; HR-MS (ESI+) m/z calculated for [C20H19NNaO4]+ = [M+Na]+ 
:360.12063; found: 360.12061. 
Diethyl 1-(o-tolyl)-1H-indole-2,3-dicarboxylate (5b) 
 
Yellow liquid (28.20 mg, 75%); FT-IR (MIR-ATR, 4000–600 cm-1)νmax = 2981, 1735, 1700, 1411, 1253, 
1181, 1111, 1054, 1010, 737, 610; 1H NMR (CDCl3, 400 MHz): δH=8.15 (d, J = 7.82 Hz, 1H), 7.16 - 7.36 
(m, 7H), 6.82 (d, J = 8.31 Hz, 1H), 4.34 (q, J = 7.17 Hz, 2H), 4.10 (q, J = 7.34 Hz, 2H), 1.92 (s, 3H), 1.34 
(t, J = 7.09 Hz, 3H), 0.98 (t, J = 7.09 Hz, 3H);13C NMR (CDCl3, 100 MHz): 164.1, 162.1, 137.2, 137.2, 
136.2, 135.2, 131.0, 129.7, 128.8, 126.9, 125.1, 124.7, 122.9, 122.3, 111.2, 108.1, 61.9, 60.4, 17.3, 14.4, 
13.7; HR-MS (ESI+) m/z calculated for [C21H21NNaO4]+ = [M+Na]+ : 374.1362; found: 374.1360. 
 
Diethyl 1-(4-bromophenyl)-1H-indole-2,3-dicarboxylate (5c) 
 
Brown liquid (15 mg, 40%); FT-IR (MIR-ATR, 4000–600 cm-1): ʋmax= 2981.52, 1735.50, 1705.87, 
1540.89, 1495.40, 1451.37, 1416.97, 1381.75, 1255.68, 1200.29, 1091.59, 1041.43, 748.16, 603.76; 1H 
NMR (CDCl3, 400 MHz): δH = 8.22 (d, J = 7.34 Hz, 1H), 7.67 (d, J = 7.82 Hz, 2H), 7.29 - 7.36 (m, 4H), 
7.17 (d, J = 7.34 Hz, 1H), 4.42 (q, J = 6.85 Hz, 2H), 4.27 (q, J = 6.85 Hz, 2H), 1.42 (t, J = 7.09 Hz, 3H), 
1.20 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 163.9, 162.2, 138.8, 137.2, 135.8, 135.5, 132.8, 
129.7, 129.2, 129.1, 128.9, 127.1, 125.3, 124.9, 123.2, 122.9, 122.5, 110.9, 109.0, 62.3, 60.6, 60.5, 14.4, 
13.9; HR-MS (ESI+) m/z calculated for [C20H18BrNNaO4]+ = [M+Na]+: 439.0344; found: 439.0344. 
 
Diethyl 1-(4-bromophenyl)-1H-indole-2,3-dicarboxylate (5c’) 
 
Yellow liquid (12 mg, 32%);  FT-IR (MIR-ATR, 4000–600 cm-1)νmax = 2981, 1702, 1443, 1409, 1251, 
1179, 1061, 694; 1H NMR (CDCl3, 400 MHz): δH = 8.29 (d, J = 1.47 Hz, 1H), 7.42 - 7.47 (m, 3H), 7.27 - 
7.34 (m, 3H), 6.98 (d, J = 8.80 Hz, 1H), 4.34 (q, J = 6.85 Hz, 2H), 4.13 - 4.18 (m, 2H), 1.34 (t, J = 7.09 Hz, 
3H), 1.05 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 163.5, 161.9, 137.2, 136.0, 135.9, 129.7, 
129.3, 127.7, 127.1, 126.8, 124.9, 116.6, 112.7, 107.6, 77.4, 77.1, 76.8, 62.3, 60.6, 14.4, 13.8; HR-MS 
(ESI+) m/z calculated for [C20H18BrNNaO4]+ =[M+Na]+ :440.0291; found:440.0290.  
Diethyl 5-bromo-1-phenyl-1H-indole-2,3-dicarboxylate (5d) 
 
Brown liquid (26 mg, 66%); FT-IR (MIR-ATR, 4000–600 cm-1): ʋmax= 2924.22, 2852.73, 1735.49, 
1703.19, 1538.89, 1505.74, 1451.12, 1411.88, 1379.90, 1255.30, 1182.41, 1150.48, 1110.04, 1054.63, 
1012.64, 790.45, 736.98, 611.61; 1H NMR (CDCl3, 400 MHz): δH= 8.19 - 8.26 (m, 1H), 7.47 - 7.55 (m, 
2H), 7.27 - 7.41 (m, 4H), 7.16 (d, J = 7.34 Hz, 1H), 4.42 (q, J = 7.17 Hz, 2H), 4.27 (q, J = 7.17 Hz, 2H), 
1.42 (t, J = 7.09 Hz, 3H), 1.19 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 163.9, 162.2, 137.2, 
135.9, 135.0, 135.0, 129.8, 128.6, 125.3, 124.9, 123.2, 122.4, 110.9, 109.0, 62.3, 60.5, 14.4, 13.8; HR-MS 
(ESI+) m/z calculated for [C22H23NNaO4]+ = [M+Na]+: 388.1519; found: 388.1516. 
Diethyl 1-(4-chlorophenyl)-1H-indole-2,3-dicarboxylate (5e) 
 
Yellow liquid (27 mg, 64%); FT-IR (MIR-ATR, 4000–600 cm-1)νmax = 2949, 1704, 1538, 1477, 1436, 1250, 
1206, 1174, 1074, 1073, 748; 1H NMR (CDCl3, 400 MHz): δH = 8.15 - 8.20 (m, 1H), 7.75 - 7.79 (m, 1H), 
7.39 - 7.51 (m, 3H), 7.29 - 7.36 (m, 2H), 6.93 (d, J = 7.34 Hz, 1H), 3.97 (s, 3H), 3.77 (s, 3H); 13C NMR 
(CDCl3, 100 MHz): 164.5, 162.0, 137.3, 136.0, 134.2, 133.7, 131.0, 130.5, 128.4, 125.3, 125.1, 123.3, 
123.1, 122.4, 111.4, 110.2, 52.8, 51.8; HR-MS (ESI+) m/z calculated for [C18H14BrNNaO4]+ =  [M+Na]+ :  
411.9978; found: 411.9990. 
Diethyl 1-(4-methoxyphenyl)-1H-indole-2,3-dicarboxylate (5f & 5f’) 
 
Yellow liquid (28 mg, 72%); FT-IR (MIR-ATR, 4000–600 cm-1)νmax = 2980, 1868, 1827, 1482, 1454, 1411, 
1252, 1209, 1159, 1117, 1058, 102, 758, 697; 1H NMR (CDCl3, 400 MHz): δH = 8.19 - 8.24  
(m, 1H), 7.69 (d, J = 1.96 Hz, 1H), 7.47 - 7.55 (m, 3H), 7.39 - 7.43 (m, 2H), 7.25 - 7.36 (m, 4H), 7.15 (d, J 
= 7.83 Hz, 1H), 7.09 (d, J = 8.80 Hz, 1H), 7.00 - 7.04 (m, 2H), 6.93 (dd, J = 9.05, 2.69 Hz, 1H), 4.41 (qd, 
J = 7.17, 2.93 Hz, 4H), 4.24 (dq, J = 11.31, 7.15 Hz, 4H), 3.91 (s, 3H), 3.88 (s, 2H), 1.41 (td, J = 7.09, 3.42 
Hz, 6H), 1.17 (t, J = 7.09 Hz, 3H), 1.13 (t, J = 7.09 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 164.2, 164.1, 
162.3, 159.9, 156.5, 137.7, 136.6, 136.2, 132.4, 129.5, 129.0, 128.9, 128.6, 127.1, 126.2, 125.4, 125.2, 
124.5, 122.9, 122.2, 115.5, 114.6, 112.1, 111.2, 107.8, 103.0, 62.1, 62.1, 60.3, 60.3, 55.7, 55.6, 14.4, 14.4, 
13.9, 13.8; HR-MS (ESI+) m/z calculated for [C21H21NNaO5]+ = [M+Na]+ :390.1312; found: 390.1314. 
 
Diethyl 1-(2,4-dimethylphenyl)-1H-indole-2,3-dicarboxylate (5g) 
 
Yellow semisolid (30.46 mg, 78%); IR (MIR-ATR, 4000–600 cm-1)νmax = 2981, 1735, 1700, 1411, 1253, 
1181, 1111, 1054, 1010,737,610; 1H NMR (CDCl3, 400 MHz): δH= 8.15 (d, J=7.82 Hz, 1H), 7.16 - 7.26 
(m, 2H), 7.01 - 7.13 (m, 3H), 6.83 (d, J = 7.83 Hz, 1H), 4.31 - 4.38 (m, 2H), 4.12 (q, J = 7.17 Hz, 2H), 2.34 
(s, 3H), 1.88 (s, 3H), 1.35 (t, J = 7.09 Hz, 3H), 1.03 (t, J = 7.34 Hz, 3H); 13C NMR (CDCl3, 100 MHz): 
164.2, 162.2, 139.7, 137.3, 136.8, 136.3, 132.5, 131.7, 128.5, 127.5, 125.1, 124.5, 122.8, 122.3, 111.2, 
107.8, 61.9, 60.3, 21.3, 17.2, 14.4, 13.7; HR-MS (ESI+) m/z calculated for [C22H23NNaO4]+ =  [M+Na]+ : 
388.1519; found: 388.1535. 
Diethyl 1-(3-methyl-2-nitrophenyl)-1H-indole-2,3-dicarboxylate (5h) 
 
Yellow liquid (28.8 mg, 68%); IR (MIR-ATR, 4000–600 cm-1)νmax = 2983, 1704, 1531, 1350, 1261, 1199, 
1199, 1174, 1074, 731; 1H NMR (CDCl3, 400 MHz): δH = 8.14 (d, J = 6.85 Hz, 1H), 7.98 (dd, J = 7.83, 
0.98 Hz, 1H), 7.40 - 7.51 (m, 2H), 7.20 - 7.32 (m, 2H), 6.80 (d, J = 7.82 Hz, 1H), 4.37 (q, J = 7.34 Hz, 2H), 
4.14 (q, J = 7.09, 1.22 Hz, 2H), 2.06 (s, 3H), 1.36 (t, J = 7.09 Hz, 3H), 1.05 (t, J = 7.09 Hz, 3H); 13C NMR 
(CDCl3, 100 MHz): 163.8, 161.4, 151.0, 137.7, 137.2, 134.8, 133.5, 133.0, 127.2, 125.6, 125.2, 123.4, 
122.7, 110.8, 110.2, 77.4, 77.1, 76.8, 62.1, 60.7, 14.4, 14.1, 13.8; HR-MS (ESI+) m/z calculated for 
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